A saúde feminina é um processo multifatorial e de muitas fases. Uma das mais importantes e frequentes problemáticas é o câncer de colo de útero, que deve ser rastreado em todos os períodos, inclusive na gravidez. Objetivo: no geral, temos: abordar a importância do exame de Papanicolau em mulheres grávidas. Já os específicos são: descrever os tipos celulares vistos nos exames de PCCU durante a gravidez, relacionando com a ação hormonal desta fase e relacionar os achados de microrganismos mais comuns nos resultados de PCCU em grávidas. Metodologia: revisão bibliográfica sistemática, com um total de 39 materiais selecionados, dentre artigos científicos, manuais ou sites institucionais em pesquisa de câncer – a maioria obtidos por bases de dados científicas e compreendendo os últimos 3 anos completos, em português e inglês. Resultados e Discussão: Foram abordados os fatores que contribuem para as taxas de adesão ao exame e também se percebeu a importância e segurança do procedimento, independente do período gestacional. Conclusão: O Papanicolau é confiável em gestantes, sua realização estando intimamente relacionada com níveis de educação sexual e de acesso a serviços de saúde, podendo melhorar significativamente a saúde feminina no país.
Since the discovery of the polymorphic nature of the IFNL4 gene, its variants have been investigated and associated with several viral diseases, with an emphasis on hepatitis C. However, the impacts of these variants on mixed-race and native populations in the northern region of Brazil are scarce. We investigated three variants of the IFNL4 gene in populations from this location, which were among the 14 most frequent variants in worldwide populations, and compared the frequencies obtained to populational data from the 1000 Genomes Project, gnomAD and ABraOM databases. Our results demonstrate that mixed-race and native populations from the northern region of Brazil present frequencies like those of European and Asian groups for the rs74597329 and rs11322783 variants, and like all populations presented for the rs4803221 variant. These data reinforce the role of world populations in shaping the genetic profile of Brazilian populations, indicate patterns of illness according to the expressed genotype, and infer an individual predisposition to certain diseases.
It is heavily suggested that one IFNL4 gene polymorphism, rs12979860 (T/C), exerts influence on the outcome of HBV infection, with the rs12979860-T allele being classified as a risk predictor, and the rs12979860-C allele being classified as a protective one. This study investigated whether the rs12979860 IFNL4 gene polymorphism presented any association with the clinical severity for HBV carriers in an admixed population in Northern Brazil. A total of 69 samples were investigated from infected people from the city of Belém-Pará. The rs12979860-T allele was positively associated with HBV infection, suggesting a higher risk of chronicity. This research’s importance is that the polymorphism influence was investigated in a population of HBV carriers with a heterogeneous genetic profile, formed through the extensive admixture of different ethnic groups, including Europeans, Africans, and Natives with indigenous heritage. This analysis is particularly important since highly mixed populations do not always follow the same association patterns previously established by studies using populations classified as more genetically homogeneous, due to a different formation process.
The rs12979860 polymorphism, related to the IFNL4 gene, is suggested as a factor that impacts fibrosis progression in hepatitis C virus (HCV) infection and exhibits a wide distribution pattern across global populations. In this retrospective cross-sectional study, we aimed to investigate the frequency of this variant in an Amazonian population from Brazil, as well as its association with liver fibrosis development and its staging in HCV carriers. Our results show a significant association of the TT genotype in the sample of patients with HCV (OR = 2.291; 95% CI = 1.088–4.826; p = 0.033) and the greater frequency of the T allele (62.1%), which is similar to the those of African populational groups. Populational genetics analysis showed significant differences in allele frequencies on global levels. The frequency of the C allele in the study population (37.8%) was like that of the African population (39.7%), and differed from all other populations, which ranged from 62.5% to 92.9%. These findings suggest that rs12979860 plays a role in susceptibility to hepatitis C. Additionally, they allow us to propose that the response to hepatitis C infection in this group may resemble that of the African population.